Effectiveness of Transcutaneous Posterior Tibial Nerve Stimulation in Multiple Sclerosis Patients With Lower Urinary Track Symptoms: A Sham Controlled Prospective Randomized Controlled Study

Status unknownNot a drug-phase studyMS (type not specified)NCT06263556

We could not find results for this trial

What it found

No results found

We found no results in the registry or in papers.

What was tested

Treatment tested

  • Transcutaneous posterior tibial nerve stimulation

Placebo

  • Sham stimulation

Given to everyone in the trial

  • Pelvic floor exercises

What it measured

Main measures

  • Incontinence Quality of Life (I-QOL)

    6 weeks (Before and after the treatment)

    Bladder, bowel and sexual functionQuality of life (reported by participants)

Other measures (3)

  • Post-void residue (PVR)

    6 weeks (Before and after the treatment)

    Bladder, bowel and sexual function
  • Bladder diary

    6 weeks (Before and after the treatment)

    Bladder, bowel and sexual function
  • International Consultation on Incontinence Questionnaire Short Form (ICIQ-SF)

    6 weeks (Before and after the treatment)

    Bladder, bowel and sexual functionQuality of life (reported by participants)

Who could take part

MS (type not specified) · 18 to 50 · EDSS 0 to 6

Show the full criteria

Inclusion criteria

* Volunteer Adults (Age 18-50) * Diagnosis of Multiple Sclerosis * Expanded Disability Status Scale (EDSS) 0-6,5 * Lower urinary track symptoms (Urinary incontinence, urgency, nocturia and/or urinary frequency) * Diagnosis of bladder disfunction with Urodynamic study within 1 months

Exclusion criteria

* Age less then 18 * Pacemaker or implantable defibrillator usage * Diabetic polyuria * Bleeding diathesis or severe bleeding tendency * Pelvic floor disfunction or nerve damage effecting tibial nerve * Currently pregnant or planning pregnancy * Active urinary infection * Active malignancy * Severe mental disability * Cognitive deficit * Expanded Disability Status Scale (EDSS) greater than or equal to 7 * Unable to attend to TPTNS treatment 2 times a week * Urodynamic findings of bladder outlet obstruction * Surgical history because of urinary incontinence * Urologic surgical history because of lower urinary track disfunction or symptoms * Diagnosis of prostatic enlargement * Diagnosis of pelvic organ prolapse

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Multiple sclerosis (MS) is the most common inflammatory disease of the central nervous system. It is characterized with demyelinated plaques affecting subcortical, brain stem, and spinal cord nerve fibers. During the course of the disease, with the affection myelinated nerve tracks, lower urinary track symptoms may occur. 50-90% of the MS patients experience lower urinary track symptoms (LUTS) such as urinary incontinence, urgency, nocturia and/or urinary frequency during the at one point of their life. Aim of this study is to determine the effects of transcutaneous tibial nerve stimulation (TTNS) on symptoms and quality of life in MS patients with LUTS.

Papers

Loading reviews and guidelines…

History

    1. Started

      Jan 2024

    2. Main results due

      Nov 2024

    3. Finished

      Dec 2024

    Assembled by software from public sources.